Volume 60, Issue 2, Pages (August 2001)

Slides:

Advertisements

Similar presentations

Renal involvement in hepatitis C infection: Cryoglobulinemic glomerulonephritis Giuseppe D’Amico Kidney International Volume 54, Issue 2, Pages

Advertisements

Epidemiology of end-stage renal disease: International comparisons of renal replacement therapy Francesco Paolo Schena Kidney International Volume 57,

Management of IgA nephropathy: Evidence-based recommendations

Volume 69, Issue 5, Pages (March 2006)

Perioperative Blood Transfusion Is Associated With Worse Clinical Outcomes in Resected Lung Cancer Ting Wang, MD, Lili Luo, MD, He Huang, MD, Jingrui.

Volume 68, Issue 2, Pages (August 2005)

Regional citrate versus systemic heparin anticoagulation for continuous renal replacement in critically ill patients Demetrios J. Kutsogiannis, R.T.Noel.

Adhesion molecule polymorphisms in chronic renal allograft failure

CHEK2*1100delC and Susceptibility to Breast Cancer: A Collaborative Analysis Involving 10,860 Breast Cancer Cases and 9,065 Controls from 10 Studies

The risk of hospitalization and modality failure with home dialysis

Progression of renal failure and hypertensive nephrosclerosis

Peter Rossing, Philip Hougaard, Hans-Henrik Parving

G protein β3 subunit C825T polymorphism in primary IgA nephropathy

Perioperative Blood Transfusion Is Associated With Worse Clinical Outcomes in Resected Lung Cancer Ting Wang, MD, Lili Luo, MD, He Huang, MD, Jingrui.

Volume 80, Issue 2, Pages (July 2011)

Volume 56, Issue 2, Pages (August 1999)

Genetic variations associated with diabetic nephropathy and type II diabetes in a Japanese population S. Maeda, N. Osawa, T. Hayashi, S. Tsukada, M.

Francesco Paolo Schena Kidney International

Steven J. Chadban, Natalie D. Staplin Kidney International

Steven G. Coca, Swathi Singanamala, Chirag R. Parikh

Volume 54, Issue 5, Pages (November 1998)

Volume 58, Issue 5, Pages (November 2000)

Comorbidity and confounding in end-stage renal disease

Volume 70, Issue 11, Pages (December 2006)

Volume 92, Issue 4, Pages (October 2017)

Volume 63, Issue 1, Pages (January 2003)

Volume 71, Issue 5, Pages (March 2007)

Long-term study of mycophenolate mofetil treatment in IgA nephropathy

Volume 71, Issue 11, Pages (June 2007)

U-shaped effect of eGFR and mortality

Volume 61, Issue 4, Pages (April 2002)

Volume 69, Issue 9, Pages (May 2006)

Volume 82, Issue 3, Pages (August 2012)

Frank Eitner, Jürgen Floege Kidney International

Volume 76, Issue 5, Pages (September 2009)

Volume 57, Issue 1, Pages (January 2000)

Volume 53, Issue 4, Pages (April 1998)

Volume 69, Issue 12, Pages (June 2006)

Volume 69, Issue 3, Pages (February 2006)

Linda F. Fried, Trevor J. Orchard, Bertram L. Kasiske

Environmental exposure to lead and progressive diabetic nephropathy in patients with type II diabetes J.-L. Lin, D.-T. Lin-Tan, C.-C. Yu, Y.-J. Li, Y.-Y.

Volume 69, Issue 8, Pages (April 2006)

Volume 67, Issue 5, Pages (May 2005)

Higher serum C-reactive protein predicts short and long-term outcomes in peritoneal dialysis-associated peritonitis N.-Y. Zalunardo, C.-L. Rose, I.W.Y.

Volume 67, Issue 3, Pages (March 2005)

Volume 80, Issue 3, Pages (August 2011)

Volume 82, Issue 7, Pages (October 2012)

Volume 58, Issue 2, Pages (August 2000)

Carmine Zoccali, Francesca Mallamaci Kidney International

Kathy E. Sietsema, Antonino Amato, Sharon G. Adler, Eric P. Brass

Volume 61, Issue 5, Pages (May 2002)

Clinical benefits of slowing the progression of renal failure

Low triiodothyronine and survival in end-stage renal disease

The Danish Renal Biopsy Register

Glucose transporter (GLUT1) allele (XbaI–) associated with nephropathy in non-insulin- dependent diabetes mellitus Zhi-Hong Liu, Tian-Jun Guan, Zhao-Hong.

Volume 66, Issue 4, Pages (October 2004)

Treatment of the primary hyperoxalurias: A new chapter

Volume 64, Issue 4, Pages (October 2003)

Charles A. Herzog Kidney International

Volume 62, Issue 5, Pages (November 2002)

Volume 75, Issue 1, Pages (January 2009)

Volume 70, Issue 3, Pages (August 2006)

Assessing the impact of different imputation methods on serial measures of renal function: The Strong Heart Study N.-M. Shara, J.-G. Umans, W. Wang,

Pentoxifylline ameliorates proteinuria through suppression of renal monocyte chemoattractant protein-1 in patients with proteinuric primary glomerular.

Volume 87, Issue 3, Pages (March 2015)

Giuseppe Remuzzi, Carlos Chiurchiu, Piero Ruggenenti

Volume 64, Issue 3, Pages (September 2003)

Ivan D. Maya, Michael Allon Kidney International

Volume 80, Issue 9, Pages (November 2011)

Prediction in idiopathic membranous nephropathy

Presentation transcript:

Volume 60, Issue 2, Pages 732-740 (August 2001) ACE gene polymorphism and IgA nephropathy: An ethnically homogeneous study and a meta-analysis Francesco P. Schena, Christian D'Altri, Giuseppina Cerullo, Carlo Manno, Loreto Gesualdo Kidney International Volume 60, Issue 2, Pages 732-740 (August 2001) DOI: 10.1046/j.1523-1755.2001.060002732.x Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 1 Renal survival in our IgAN patients with the DD (17 events; solid line), ID (19 events; dashed line), and II (10 events; dotted line) genotypes. Log rank test, P = 0.48. Kidney International 2001 60, 732-740DOI: (10.1046/j.1523-1755.2001.060002732.x) Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 2 Association between ACE I/D polymorphism (ACE DD + ID versus II) and IgA nephropathy. Odds ratio between IgAN patients and controls are reported. OR with 95% confidence intervals (CI) for each study together with the pooled estimate are shown. The solid vertical line shows an OR of 1. Kidney International 2001 60, 732-740DOI: (10.1046/j.1523-1755.2001.060002732.x) Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 3 Association of ACE gene polymorphisms (DD + ID vs. II) and progression of renal damage in IgAN patients. Odds ratio between IgAN patients with and without deteriorating renal function are reported. Kidney International 2001 60, 732-740DOI: (10.1046/j.1523-1755.2001.060002732.x) Copyright © 2001 International Society of Nephrology Terms and Conditions